Lazari Capital Management’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$221K Buy
+2,608
New +$210K 0.07% 163
2026
Q1
Sell
-2,641
Closed -$208K 179
2025
Q4
$208K Buy
2,641
+16
+0.6% +$1.27K 0.07% 146
2025
Q3
$216K Hold
2,625
0.07% 140
2025
Q2
$211K Buy
2,625
+63
+2% +$4.86K 0.08% 139
2025
Q1
$206K Buy
2,562
+8
+0.3% +$665 0.08% 140
2024
Q4
$209K Sell
2,554
-254
-9% -$21.1K 0.08% 135
2024
Q3
$232K Buy
+2,808
New +$210K 0.1% 130
2024
Q2
Sell
-2,797
Closed -$207K 149
2024
Q1
$207K Sell
2,797
-300
-10% -$20.9K 0.11% 107
2023
Q4
$205K Buy
+3,097
New +$194K 0.12% 106
2023
Q3
Sell
-3,597
Closed -$203K 127
2023
Q2
$203K Buy
+3,597
New +$200K 0.11% 109

Other funds holding MET

Lazari Capital Management's MET Position: Q2 2026 in Review

Lazari Capital Management opened a new position in MetLife (MET) in Q2 2026: 2,608 shares worth $221K. The stake represents 0.07% of the portfolio and ranks #163 among its holdings. This is a return to the name: Lazari Capital Management previously reported a position in MET as recently as Q4 2025.

Lazari Capital Management first reported a position in MET in Q2 2023 and has held it in 10 quarters since. The position peaked at $232K in Q3 2024. 624 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Lazari Capital Management held 2,608 shares of MetLife worth $221K as of Q2 2026.
  • MetLife was a new Lazari Capital Management position in Q2 2026.
  • MetLife made up 0.07% of Lazari Capital Management's portfolio in Q2 2026, its #163 holding.
  • Lazari Capital Management first reported a position in MetLife in Q2 2023 and has held it in 10 quarters since.
  • Lazari Capital Management's MetLife position peaked at $232K in Q3 2024.
  • 624 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Lazari Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.